Cargando…
Newly Diagnosed Diabetes Mellitus During COVID-19: The New Pandemic – A Literature Review
PURPOSE OF REVIEW: Coronavirus disease 2019 (COVID-19) has caused a spike in newly diagnosed diabetes mellitus (NDDM). NDDM and COVID-19 infection are not well established as a cause-and-effect relationship; hence, the present review aims to define the underlying causes and consequences of COVID-19...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9510456/ https://www.ncbi.nlm.nih.gov/pubmed/36187907 http://dx.doi.org/10.1007/s40475-022-00268-3 |
_version_ | 1784797445152047104 |
---|---|
author | Knebusch Toriello, Nicole Prato Alterio, Natalia María Ramírez Villeda, Lourdes María |
author_facet | Knebusch Toriello, Nicole Prato Alterio, Natalia María Ramírez Villeda, Lourdes María |
author_sort | Knebusch Toriello, Nicole |
collection | PubMed |
description | PURPOSE OF REVIEW: Coronavirus disease 2019 (COVID-19) has caused a spike in newly diagnosed diabetes mellitus (NDDM). NDDM and COVID-19 infection are not well established as a cause-and-effect relationship; hence, the present review aims to define the underlying causes and consequences of COVID-19 infection in relation to the condition. RECENT FINDINGS: β-Cells are infiltrated by SARS-CoV-2, causing glycometabolic dysfunction and insulin dysregulation. The disease causes systemic inflammation and pro-inflammatory cytokines, as well as hormonal changes that lead to insulin resistance and hyperglycemia that are difficult to manage. As a result of NDDM, complications related to COVID-19 infection become more severe. SUMMARY: NDDM related to COVID-19 infection complicates hospitalization outcomes and adversely affects quality of life in patients. There are many possible causes and consequences associated with NDDM, but for establishing preventive measures and treatments for NDDM, more evidence regarding its epidemiology, physiopathology, etiology, and nutritional aspects is required. |
format | Online Article Text |
id | pubmed-9510456 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Springer International Publishing |
record_format | MEDLINE/PubMed |
spelling | pubmed-95104562022-09-26 Newly Diagnosed Diabetes Mellitus During COVID-19: The New Pandemic – A Literature Review Knebusch Toriello, Nicole Prato Alterio, Natalia María Ramírez Villeda, Lourdes María Curr Trop Med Rep Metabolism in Tropical Medicine (K Schlosser-Montes, Section Editor) PURPOSE OF REVIEW: Coronavirus disease 2019 (COVID-19) has caused a spike in newly diagnosed diabetes mellitus (NDDM). NDDM and COVID-19 infection are not well established as a cause-and-effect relationship; hence, the present review aims to define the underlying causes and consequences of COVID-19 infection in relation to the condition. RECENT FINDINGS: β-Cells are infiltrated by SARS-CoV-2, causing glycometabolic dysfunction and insulin dysregulation. The disease causes systemic inflammation and pro-inflammatory cytokines, as well as hormonal changes that lead to insulin resistance and hyperglycemia that are difficult to manage. As a result of NDDM, complications related to COVID-19 infection become more severe. SUMMARY: NDDM related to COVID-19 infection complicates hospitalization outcomes and adversely affects quality of life in patients. There are many possible causes and consequences associated with NDDM, but for establishing preventive measures and treatments for NDDM, more evidence regarding its epidemiology, physiopathology, etiology, and nutritional aspects is required. Springer International Publishing 2022-09-26 2022 /pmc/articles/PMC9510456/ /pubmed/36187907 http://dx.doi.org/10.1007/s40475-022-00268-3 Text en © The Author(s), under exclusive licence to Springer Nature Switzerland AG 2022, Springer Nature or its licensor holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law. This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic. |
spellingShingle | Metabolism in Tropical Medicine (K Schlosser-Montes, Section Editor) Knebusch Toriello, Nicole Prato Alterio, Natalia María Ramírez Villeda, Lourdes María Newly Diagnosed Diabetes Mellitus During COVID-19: The New Pandemic – A Literature Review |
title | Newly Diagnosed Diabetes Mellitus During COVID-19: The New Pandemic – A Literature Review |
title_full | Newly Diagnosed Diabetes Mellitus During COVID-19: The New Pandemic – A Literature Review |
title_fullStr | Newly Diagnosed Diabetes Mellitus During COVID-19: The New Pandemic – A Literature Review |
title_full_unstemmed | Newly Diagnosed Diabetes Mellitus During COVID-19: The New Pandemic – A Literature Review |
title_short | Newly Diagnosed Diabetes Mellitus During COVID-19: The New Pandemic – A Literature Review |
title_sort | newly diagnosed diabetes mellitus during covid-19: the new pandemic – a literature review |
topic | Metabolism in Tropical Medicine (K Schlosser-Montes, Section Editor) |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9510456/ https://www.ncbi.nlm.nih.gov/pubmed/36187907 http://dx.doi.org/10.1007/s40475-022-00268-3 |
work_keys_str_mv | AT knebuschtoriellonicole newlydiagnoseddiabetesmellitusduringcovid19thenewpandemicaliteraturereview AT pratoalterionataliamaria newlydiagnoseddiabetesmellitusduringcovid19thenewpandemicaliteraturereview AT ramirezvilledalourdesmaria newlydiagnoseddiabetesmellitusduringcovid19thenewpandemicaliteraturereview |